The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to test whether the dynamic changes of CD4+T lymphocytes can predict infections in patients with primary nephrotic syndrome . The main questions it aims to answer are: * whether the dynamic changes of CD4+T lymphocytes can predict infections in patients with primary nephrotic syndrome * effect of different immunosuppressive therapy on the number and function of T lymphocyte subsets in patients with primary nephrotic syndrome Participants will be divided into infection group and non-infection group according to whether they are infected

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 75
Healthy Volunteers: t
View:

• Age ≥ 14 years and\<75 years.

• It meets the diagnostic criteria of primary nephrotic syndrome, i.e. a. A large amount of proteinuria (24h urine protein quantity \> 3.5g/d); b. Hypoalbuminemia (liver function: albumin\<30g/L); c. Edema; d. The blood lipid is elevated. Among them, item a and b are necessary conditions for diagnosis.

• Nephrocentesis pathology indicates the pathological type of nephrotic syndrome (minimal change glomerulonephritis, membranous nephropathy, focal segmental glomerulonephritis, membranous proliferative glomerulonephritis, mesangial proliferative glomerulonephritis).

• Glucocorticoids or corticosteroids combined with immunosuppressants should be used clinically.

Locations
Other Locations
China
the fifth affiliated hospital of SUN YAT-SEN university
RECRUITING
Zhuhai
Contact Information
Primary
Wei Ping Zhu
zhuwp@mail.sysu.edu.cn
13926927805
Time Frame
Start Date: 2022-11-16
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 156
Treatments
infection group
non-infection group
Related Therapeutic Areas
Sponsors
Leads: Fifth Affiliated Hospital, Sun Yat-Sen University
Collaborators: Nanfang Hospital, Southern Medical University, Guangdong traditional Chinese medicine hospital, Zhuhai

This content was sourced from clinicaltrials.gov